Spex Capital and London’s life sciences cluster organisation MedCity launched their joint call at the close of 2021, as part of their exclusive partnership to identify and fund the next generation of digital health and medtech innovators.
Following a thorough review of over 200 applicants under the scrutiny of two independent panels, we shortlisted 35 companies to progress to the next stage, involving in-person interviews with our Teams, Advisory Boards and other industry leaders. We have now refined our selection to 20 outstanding candidates that are progressing to the deep due diligence stage and hopefully become part of our portfolio companies.
We would like to take this opportunity to thank all the outstanding applicants across the call.
If you have any questions, please send queries to: email@example.com